Gene · 2805
Papers1,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer. | Cancers (Basel) | 2023 | 37444595 | PubTator, text mining | PubMed |
| Endogenous Tryptophan-Derived Ah Receptor Ligands are Dissociated from CYP1A1/1B1-Dependent Negative-Feedback. | Int J Tryptophan Res | 2023 | 37434789 | PubTator, text mining | PubMed |
| Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer. | Cancer Commun (Lond) | 2023 | 37434399 | PubTator, text mining | PubMed |
| Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer's disease. | NPJ Regen Med | 2023 | 37429840 | PubTator, text mining | PubMed |
| Comparison in conjunctival-Tenon's capsule thickness, anterior scleral thickness and ciliary muscle dimensions between Caucasians and Hispanic by optical coherence tomography. | Int Ophthalmol | 2023 | 37405569 | PubTator, text mining | PubMed |
| Increased glucose availability sensitizes pancreatic cancer to chemotherapy. | Nat Commun | 2023 | 37380658 | PubTator, text mining | PubMed |
| Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma. | Int J Mol Sci | 2023 | 37373523 | PubTator, text mining | PubMed |
| Mitochondrial Regulation of Ferroptosis in Cancer Therapy. | Int J Mol Sci | 2023 | 37373183 | PubTator, text mining | PubMed |
| c-Myc protects hepatocellular carcinoma cell from ferroptosis induced by glutamine deprivation via upregulating GOT1 and Nrf2. | Mol Biol Rep | 2023 | 37358765 | PubTator, text mining | PubMed |
| Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model. | Mol Cell Proteomics | 2023 | 37348606 | PubTator, text mining | PubMed |
| Mass Spectrometry Imaging Reveals Abnormalities in Cardiolipin Composition and Distribution in Astrocytoma Tumor Tissues. | Cancers (Basel) | 2023 | 37345179 | PubTator, text mining | PubMed |
| TMT-Based Quantitative Proteomic and Physiological Analyses on Serums of Chinese Patients with Active Vitiligo. | Clin Cosmet Investig Dermatol | 2023 | 37303983 | PubTator, text mining | PubMed |
| Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1. | Pathol Res Pract | 2023 | 37301086 | PubTator, text mining | PubMed |
| De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence. | Nat Cell Biol | 2023 | 37291265 | PubTator, text mining | PubMed |
| Maintenance of neuronal fate and transcriptional identity. | Biol Open | 2023 | 37272626 | PubTator, text mining | PubMed |
| A plasma proteomic approach in patients with heart failure after acute myocardial infarction: insights into the pathogenesis and progression of the disease. | Front Cardiovasc Med | 2023 | 37265567 | PubTator, text mining | PubMed |
| Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma. | Cancer Discov | 2023 | 37262067 | PubTator, text mining | PubMed |
| The CD73 immune checkpoint promotes tumor cell metabolic fitness. | Elife | 2023 | 37261423 | PubTator, text mining | PubMed |
| PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response. | Front Oncol | 2023 | 37260977 | PubTator, text mining | PubMed |
| Integrating eQTL and GWAS data characterises established and identifies novel migraine risk loci. | Hum Genet | 2023 | 37245199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2805/papers?page=11